. hp/ebis.xnkxnib.gov Estrogens influence the growth, differentiation, development, and function of several target tissues involved in reproduction, cardiovascular performance, bone maintenance, homeostasis, and behavior. Many of these processes are modulated as a result of estrogen receptor (ER)-mediated expression of estrogen responsive genes. The binding of estrogens to the ligand binding domain of the ER causes dissociation of associated heat shock proteins and subsequent dimerization of ligand-occupied ERs. The homodimer complex then interacts with specific DNA sequences referred to as estrogen response elements (ERE) located in the regulatory region of estrogen-inducible genes. ER complexes that are bound to an ERE recruit additional transcription factors, leading to increases in gene transcription (1,4. In addition to their known normal physiological functions, estrogens have also been implicated in the development of hormone-dependent cancers of the breast, ovaries, endometrium, and prostate (3, 4) . Studies suggest that estrogens promote the growth and invasiveness of hormone-dependent tumors by inducing genes such as growth factors, growth factor receptors, protooncogenes, and proteases, which contribute to cell proliferation, invasion, and metastasis (4-8. Estrogenic chemicals or mixtures have been defined as substances whose effects are mediated through the estrogen receptor, initiating a cascade of cellular/tissue effects similar to those initiated by 17,-estradiol (E2). In contrast, chemicals or complex mixtures whose effects resemble those of estrogen but are not mediated through the estrogen receptor are referred to as estrogenlike (9) . Recently, xenobiotics capable of eliciting estrogenic activities have also been implicated as contributing factors in the development of hormone-dependent cancers, as well as compromising the reproductive fitness of humans and wildlife (10-14. These chemicals, commonly referred to as environmental estrogens, xenoestrogens, or exoestrogens, encompass a wide range of compounds including natural products, environmental pollutants, pharmaceuticals, and industrial chemicals. Many exoestrogens do not share any structural similarity to the prototypical estrogen, E2, the preeminent female sex steroid (13) . However (14, 15) .
Polychlorinated biphenyls (PCBs) are a class of synthetic, persistent, lipophilic, halogenated aromatics that, despite their discontinued use, are still found throughout the environment as complex mixtures (16, 17) .
PCBs induce a broad spectrum of toxic and biochemical responses in a number of in vitro and in vivo models. Many of the responses elicited by coplanar PCBs correlate with their binding affinity to the aryl hydrocarbon receptor (AhR), which is believed to mediate several of the effects induced by these compounds (18) . However, noncoplanar PCBs that exhibit low or negligible binding affinity for the AhR have also been shown to evoke a number of responses including immunotoxicity and neurotoxicity (19) (20) (21) (22) (23) . Recent studies suggest that some of these effects may be due to interactions with calcium-dependent pathways (19, 21, 23 (36) (37) (38) (39) (40) (41) (42) . Based on their chemical structure and estrogenic activities, it has been suggested that only those PCB congeners that possess orthosubstituents are capable of eliciting an estrogenic response following hydroxylation at a vacant para position (30) . Results obtained by Soto et al. (34) support this hypothesis because 2,5-dichlorobiphenyl was found to be inactive in the MCF-7 cell proliferation assay (E-Screen), whereas ortho-, meta-, and para-hydroxylation on the unsubstituted ring significantly increased activity, with para-hydroxylation conferring the greatest effect. Similarly, it has been proposed that methoxychlor and benz[a]anthracene also require metabolic activation to hydroxylated metabolites to elicit estrogenic effects (43, 44) . Numerous (30, 39, .
Taken together, these findings bolstered preliminary epidemiological reports that found higher levels of PCBs in women with breast cancer (48, 49) , leading some to suggest that exposure to estrogenic PCBs may be a contributing factor in the increased incidence of hormone-dependent diseases and compromised reproductive fitness in humans and wildlife (10, 11, 50, 51 (12, 57, 58 10 mM sodium pyruvate, 2 mg/ml lipoic acid, 1.38 mg/ml vitamin B12, 0.5 mM zinc sulfate, 2 mM glutamine, 50 g/ml gentamycin, 100 IU penicillin, 100 pg/inl streptomycin, and 2.5 pg/ml amphotercin B. The cells were grown at 37°C in a 5% CO2 humidified environment.
Transfections and reporter gene assays. Transient transfections and gene transcription assays were performed essentially as previously described (47, (62) (63) (64) . Briefly, MCF-7 cells were seeded at approximately 50% confluency in 6-well tissue culture plates in medium supplemented with 5% dextrancoated charcoal-treated fetal bovine serum (DCC-FBS) and allowed to attach for 6 hr. Cells were then transiently transfected by the calcium phosphate co-precipitation method (65) Transfected MCF-7 cells were exposed to the following final concentrations: 0.1, 1, and 10 pM of test compound; 1 pM-10 nM E2. or DMSO (solvent) alone. Final concentrations were obtained by adding 2.5 pl of test chemical to 2.5 ml of medium. Following incubation with the test compound for 24 hr, cells were harvested and assayed for luciferase activity according to the method described by Brasier et al. (67) .
The reference plasmid, pCMV-lacZ or pCH 110, was co-transfected as an internal control to correct for differences in transfection efficiencies and sample extractions. IGalactosidase activity was measured according to standard protocols (65) . Transiently transfected MCF-7 cells were treated in duplicate and two samples were taken from each replicate. Therefore, the means and standard deviations were calculated from four measurements. Each experiment was repeated three times. Values were reported as a percentage relative to the maximum induction observed with E2. (46, 47, (62) (63) (64) (71) (72) (73) . E2 induced a dose-dependent increase in luciferase activity, reaching a 100% response (69-fold induction) at 50 nM E2 (Fig. 3) . PCB 104 induced luciferase activity in a dose-dependent manner with a relative activity of 45% (31-fold) at a concentration of 10 M, the highest concentration tested, when compared to the 100% response observed with E2. The para-hydroxylated derivative HO-PCB 104 produced a modest increase in estrogenicity at 0.1 and 1.0 pM, reaching a maximum of 15-fold induction. However, the observed induction was only 9-fold at 10 pM. Visual inspection of the cells and measurement of ,B-galactosidase activity did not indicate that the low level of 17m5-G-Luc activity was due to HO-PCB 104 toxicity (data not shown). PCB 155 showed minimal estrogenic activity (Fig. 3) . Induction by E2, PCB 104, and HO-PCB 104 was completely inhibited by the pure antiestrogen ICI 164,384 (100 nM), thus confirming the role of the ER in mediating the response (Fig. 4 ).
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Log concentration (M) Figure 3 . The estrogen receptor (ER)-mediated effects of 17)i-estradiol (E2), PCB (Fig. 5B) . However, the activity induced by 1 and 10 pM PCB 104 decreased sixfold after 24 hr and remained low over the 36 and 48 hr incubation periods (Fig. 5B) . This dramatic decline in luciferase activity cannot be attributed to toxicity because the activity of the constitutively expressed 1-galactosidase expression vector (i.e., pCH1 10) did not decrease, but remained consistent over the same time period (data not shown). PCB 155 did not significantly induce luciferase at any concentration tested at any time point (data not shown). Although maximum induction was observed following a 16-hr incubation period, 24-hr incubation periods were used in order for comparison to be consistent with previous studies.
In order to investigate the effects of E2 plus PCBs on gene expression, MCF-7 cells transiently transfected with Gal4-HEGO and 17m5-G-Luc were treated with 1 nM E2 and increasing concentrations of PCB 104, HO-PCB 104, and PCB 155 (0.1, 1, and 10 pM). As shown in Figure 4 , cotreatment with E2 plus PCB 104 had little effect when compared to E2 alone. However, HO-PCB 104 exhibited additive effects at 10 pM in the presence of E2, whereas lower concentrations of HO-PCB 104 showed little effect when compared to E2 alone. In contrast, PCB 155 significantly decreased E2-induced luciferase activity in a dose-dependent manner.
Metabolic hydroxylation of PCBs is preferentially targeted to the para position (74, 75 (Fig. 6A) . Cell proliferation was induced twofold following treatment with 1 pM PCB 104, whereas at 10^M , PCB 104 dramatically decreased cell numbers to below control levels. HO-PCB 104 (0.1 1M) was found to be more potent, inducing a fourfold increase in cell proliferation. Maximum induction (fivefold) of cell proliferation was observed with 1 11M HO-PCB 104. Cell numbers dramatically decreased to below control levels when incubated with 10 pM HO-PCB 104. PCB 155 induced small but significant increases in cell growth; however, the response did not appear to be dose dependent.
Co-treatment of MCF-7 cells with 1 nM E2 plus 1 pM PCB 104 or 1 pM HO-PCB 104 resulted in significant increases in cell growth compared to cells treated with E2 alone (Fig. 6B) . However, dramatic decreases in cell numbers were once again observed after treatment of the cells with 10 pM PCB 104 or HO-PCB 104 (Fig. 6B) .
Co-treatment with 1 nM E2 plus PCB 155 at 0.01, 0.1, and 1.0 pM increased cell numbers when compared to E2 alone, but not in a dose-dependent manner. In contrast, 10 (15) . Although these results demonstrate that PCB 104, HO-PCB 104, and PCB 155 can interact with the mouse uterine ER, they do not provide sufficient evidence to conclude that these compounds are estrogenic. In addition, results obtained from competitive binding assays do not provide information regarding the agonist or antagonist activities of a chemical.
Recombinant receptor/reporter gene expression and MCF-7 cell proliferation assays were also used to investigate the agonist and antagonist activities of the three aforementioned compounds. PCB 104 and HO-PCB 104 exhibited significant agonist activity in the gene expression assay. GC-MS analysis confirmed that the induction of 17m5-G-Luc activity was due to PCB 104 because neither the expected HO-PCB 104 metabolite nor any isomers of this product were detected in the media. In addition, GC-MS analysis also confirmed that there were no measurable changes in PCB 104 levels in the media. Luciferase activity induced by PCB (15, 77, 78) . (84, 86, 87) . Moreover, a semiquantitative procedure, which compares the disappearance of leukocytes and the appearance of cornified epithelial cells (68) Although the PCB congeners used in this study are not detected at appreciable levels in the environment, they are useful probes to investigate the importance of para-hydroxylation and para-chlorination on the estrogenic activity of noncoplanar PCBs, which represent the majority of relevant congeners found in environmental and biological matrices (17) . The estrogenic activities of PCB 104 and PCB 155 support the theoretical structural requirements predicted for PCB estrogenicity. Both congeners are conformationally restricted about the twist bond due to ortho-substitution and both also possess para-substituents (29) . In addition, these structural features confer differential cytochrome P450 induction patterns. For example, coplanar PCBs are primarily CYPlA inducers, noncoplanar PCBs are primarily CYP2B inducers, and mono-ortho coplanar congeners can be classified as mixed inducers (18) . Metabolism of these three classes of PCBs is similar with preferential hydroxylation on the vacant para and meta positions. However, they differ in their ability to act as substrates for P4501A or 2B. P4502B from phenobarbital-treated rats has been shown to primarily hydroxylate noncoplanar, di-ortho-substituted dichlorobiphenyls, while coplanar dichlorobiphenyl congeners containing meta-and para-substitution, are primarily hydroxylated following incubation with purified P4501A obtained from tnapthoflavone-treated rats (75) . Monoortho-substituted dichlorobiphenyl congeners are metabolized to a similar extent by both isozymes. Therefore, substitution patterns can influence P450 isozyme induction, thus affecting the extent and type of their own metabolism. Biphenyls have been shown to be preferentially hydroxylated on the para position in vitro (88) and in vivo (89) . 2-and 3-Hydroxybiphenyl metabolites were also detected to a lesser degree with species-specific differences (89) . Moreover, a single chlorine atom has been shown to direct metabolism exclusively to the unchlorinated ring, yielding a single major metabolite that is hydroxylated on the para position (90, 91) . Although metabolism can be restricted when both rings are chlorinated (92) , the existence of adjacent unsubstituted carbon atoms, preferably at the 3,4-position (93, 94) greatly facilitates hydroxylation on the para position via arene oxide intermediates (91) . Taken together, these results strongly suggest that multi-ortho-substituted PCB congeners with vacant lateral positions are amenable to para-hydroxylation, thus conforming to the predicted structural requirements necessary for estrogenicity (29) . The increased estrogenic activity observed in this study for PCB 104 following hydroxylation on the para position (i.e., HO-PCB 104) provides experimental support for the theoretical requirements for PCB estrogenicity as suggested by Waller et al. (29) bBoundaries for the human estrogen receptor 0i D, E, and F domains were determined based on amino acid sequence similarity to the Japanese eel estrogen receptor. 101); and 2,3,5,6,2',5'-hexachlorobiphenyl (PCB 151)] may also be susceptible to parahydroxylation and therefore conform to the structural requirements necessary for ER binding.
The ER is a member of the nuclear receptor superfamily, which can be divided into six domains labeled A-F (2. Although the activities of estrogen and the ER are highly conserved between species, the amino acid sequence of the region responsible for ligand binding and ligand-dependent gene expression (i.e., domains D, E, and F) are not as well conserved (Table 2) . Examination of the amino acid sequence of the ER ligand binding domain (i.e., domain E) indicates that significant differences in similarity exist between species (Fig. 7) . For example, the hormone binding domain (i.e., domain E) of the human ER (hER) shares 93% identity with the chicken ER, 82% identity with the Xenopus laevis ER (xER), but only 60% similarity with the rainbow trout ER (rtER). The percent identity between species is even less when the D, E, and F domains are considered as a functional unit (Table 2 and Fig. 7 ) because all three domains contribute to ligand binding and gene expression (109) . This leads to serious doubts regarding the viability of using one surrogate species to accurately predict responses in other species, especially when investigating structurally diverse exoestrogens. For example: 1) the rtER has a 10-fold lower binding affinity for E2 than hER (110) ; 2) the rtER exhibits a fivefold lower affinity for diethylstilbestrol ( Figure 7 . Comparison of the amino acid sequence similarities of the individual D, E, and F domains for the estrogen receptor (ER) a. All species were compared to the human estrogen receptor. Amino acid sequence similarities were determined using MacVector (Oxford Molecular Group, Beaverton, OR).
Numbers within the domains represent the percent sequence similarity. Numbers above the domains represent the amino acid boundary of the domain. Boundaries for the human ER j D, E, and F domains were determined based on amino acid sequence similarity to the Japanese eel ER. and hER ligand binding domains (i.e., domains D, E, and F) share only 40% identity, yet it is assumed that the two receptors exhibit comparable binding affinities and ligand preferences.
Although these examples clearly illustrate that species-specific ligand binding preferences and affinities exist, these differences may also be attributed to the use of different competitive binding assay protocols and/or differences within ER containing cytosolic preparations. Nevertheless, these examples demonstrate that ligand preferences and affinities for ERs may differ significantly between species; therefore, it may not be possible to extrapolate results from a single surrogate species-based assay to other species. Consequently, further research is needed to investigate the potential speciesspecific estrogenic activity of other exoestrogens including parent PCBs and their hydroxylated metabolites.
To summarize, results from this study have demonstrated that selected PCBs may not require oxidation to a hydroxylated metabolite to elicit ER-mediated activities. Hydroxylation of the parent PCB was found to enhance its binding affinity and potency, although the latter affect was endpoint specific. Further studies are required in order to identify other estrogenic PCBs and also to examine the role of variable ER ligand binding domain sequences in determining species-specific sensitivities to exoestrogens.
